Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Opinion
Events
About Us
psilocybin
Clairvoyant Expects to Bring Psilocybin Treatment to Market By 2025
April
5
,
2024
Open:Minds Expo
March
22
,
2024
Cybin Raises $150 Million Via Oversubscribed Private Placement
March
20
,
2024
After ‘Positive’ FDA Meeting, Cybin Looks Ahead to Phase 3 CYB003 Program
March
14
,
2024
FDA Green-Lights Expedited Review Path for Cybin’s CYB003 Psilocybin Molecule
March
13
,
2024
Denver Asks Citizens to Help Craft Psilocybin Policies
March
6
,
2024
«
‹
4
5
6
7
›
»